20/20 Biolabs, Inc. - AIDX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 06, 2026 | Chief Financial Officer | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Apr 06, 2026 | Chief Operating Officer | A | A | 150,000.0 | 0.0 | 0.0 | 150,000.0 | View | |
| Mar 04, 2026 | Chief Executive Officer | A | A | 352,936.0 | 0.0 | 0.0 | 352,936.0 | View | |
| Feb 23, 2026 | — | C | D | 6,135.0 | — | — | 0.0 | View | |
| Feb 23, 2026 | — | C | D | 13,029.0 | — | — | 0.0 | View | |
| Feb 23, 2026 | — | C | A | 6,135.0 | 0.0 | 0.0 | 30,275.0 | View | |
| Feb 23, 2026 | — | C | A | 13,029.0 | 0.0 | 0.0 | 24,140.0 | View | |
| Feb 23, 2026 | — | C | D | 31.0 | — | — | 0.0 | View | |
| Feb 23, 2026 | — | C | A | 31.0 | 0.0 | 0.0 | 31.0 | View | |
| Feb 23, 2026 | — | C | D | 7,669.0 | — | — | 0.0 | View | |
| Feb 23, 2026 | — | C | A | 7,669.0 | 0.0 | 0.0 | 14,335.0 | View | |
| Feb 23, 2026 | — | C | D | 7,700.0 | — | — | 0.0 | View | |
| Feb 23, 2026 | — | C | A | 7,700.0 | 0.0 | 0.0 | 7,700.0 | View |